NCT02128945View on ClinicalTrials.gov

Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

May 31, 2016

Conditions
Untreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma Patients
Interventions
OTHER

[18F] - Fludarabine PET/CT

\[18F\] - Fludarabine PET/CT before treatment

Trial Locations (1)

14000

University Hospital, Caen

All Listed Sponsors
collaborator

CNRS, UMR ISTCT 6301, LDM-TEP Groupe, GIP Cyceron, Caen, France

UNKNOWN

lead

University Hospital, Caen

OTHER

NCT02128945 - Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies | Biotech Hunter | Biotech Hunter